Skip to main content

Quality Control, Quality Assurance, Production and Packing Jobs at Emcure

Emcure is fast-growing Indian pharmaceutical company engaged in developing, manufacturing, and marketing a broad range of pharmaceutical products globally.
Ipca Laboratories Interview : Quality Control, Quality Assurance, Production and Packing Jobs
Ipca Laboratories Interview : Quality Control, Quality Assurance, Production and Packing Jobs

For more than 60 years. Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world's most discerning drug regulatory authorities like UK-MHRA. EDQM-Europe. and WHO Geneva, among others.

Syneos Health Hiring Safety & PV Intern / Trainee
Syneos Health Hiring Safety & PV Intern / Trainee
Records all ICSR documentation and tracks in accordance with Sponsor / customer specifications; distributes incoming mail and faxes if required.
GLP-1 Obesity Drugs May Reduce Fat While Preserving Muscle, Study Finds
GLP-1 Obesity Drugs May Reduce Fat While Preserving Muscle, Study Finds
A new real-world study presented at the European Congress on Obesity 2026 suggests that popular obesity medications such as semaglutide and tirzepatide may help patients lose mostly fat while preserving much of their muscle mass.
Experts Raise Concerns Over UK’s Fast-Track Drug Approval System
Experts Raise Concerns Over UK’s Fast-Track Drug Approval System

A newly introduced drug approval pathway in the United Kingdom is facing criticism from healthcare experts, who argue that the system may favor pharmaceutical companies more than patients or the public healthcare system. According to an analysis published in The BMJ, the accelerated process could lead to quicker market access for medicines without guaranteeing meaningful benefits for patients.

Heart Attack Survivors May Face Faster Memory Decline, New Study Warns
Heart Attack Survivors May Face Faster Memory Decline, New Study Warns

People who have survived a heart attack could be at a greater risk of experiencing faster declines in memory and thinking abilities as they age, according to a new study published in the journal Stroke.

Researchers found that adults with a prior heart attack had a significantly higher likelihood of developing cognitive impairment over time compared to individuals without a history of heart attack. The findings highlight a growing connection between heart health and brain health, especially among older adults.

FDA Approves BeOne’s BEQALZI for Blood Cancer
FDA Approves BeOne’s BEQALZI for Blood Cancer
BeOne Medicines Ltd. a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to BEQALZI™ (bee-KAHL-zee; sonrotoclax), a foundational, next-generation BCL2 inhibitor, for the treatment of adult patients with relapsed or refractory (R/R) mantle cell lymphoma
AstraZeneca’s Imfinzi Combination Shows Survival Benefit in Bladder Cancer Trial
AstraZeneca’s Imfinzi Combination Shows Survival Benefit in Bladder Cancer Trial
High-level results from a planned interim analysis of the VOLGA Phase III trial showed perioperative treatment with Imfinzi (durvalumab) in combination with neoadjuvant enfortumab vedotin (EV) demonstrated statistically significant and clinically meaningful improvements in event-free survival (EFS) and overall survival (OS) in patients with muscle-invasive bladder cancer (MIBC) versus standard of care.
23 Openings Pharma candidates under Ministry of Science & Technology, IIIM
23 Openings Pharma candidates under Ministry of Science & Technology, IIIM
M.Sc / M.Pharm in Pharmaceutical Chemistry, Analytical Chemistry, Chemistry, Pharmaceutical Analysis, or allied areas from a recognized University or equivalent. 
Recruitment for Biochemistry, Chemistry, Pharma, Biotechnology candidates at IITR
Recruitment for Biochemistry, Chemistry, Pharma, Biotechnology candidates at IITR

The Indian Institute of Toxicology Research (IITR), established in 1965, a constituent laboratory of Council of Scientific & Industrial Research (CSIR) engaged in the Research & Development in the areas of Environmental Toxicology, Predictive Toxicology, Health Risk Assessment, Preventive Toxicology, Inhalation Toxicology, Analytical Toxicology, and also National S&T Missions. IITR has two campuses; the main campus is located at the centre of Lucknow City and the other campus at a distance of approx. 20 km from the main campus.